Food anaphylaxis.
The author reviews some aspects of the worldwide problem of anaphylaxis to foods, regarding its prevalence clinical manifestations and present classification as well as the preventive and therapeutic measures that are presently available. Some of the future therapeutic perspectives are also discussed.
Branco Ferreira
Manuel
M
Immunoallergology Unit, Hospital de Santa Maria, Faculty of Medicine Lisbon, Portugal. manefer-510@clix.pt
Palma-Carlos
Antero
A
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000485:Allergens / Q000009:adverse effects / Q000627:therapeutic use; D000707:Anaphylaxis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D000799:Angioedema / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D000818:Animals; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D003429:Cross Reactions; D003888:Desensitization, Immunologic; D004353:Drug Evaluation, Preclinical; D004837:Epinephrine / Q000627:therapeutic use; D005512:Food Hypersensitivity / Q000150:complications* / Q000175:diagnosis / Q000178:diet therapy / Q000453:epidemiology; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D051379:Mice; D008517:Phytotherapy; D012307:Risk Factors
D000305:Adrenal Cortex Hormones; D000485:Allergens; D018926:Anti-Allergic Agents; D001993:Bronchodilator Agents; D006634:Histamine H1 Antagonists; D004837:Epinephrine